EMBO Young Investigator
Sam Behjati
YIP 2021–2025
Wellcome Sanger Institute, Cambridge, United Kingdom
Unravelling the origin of childhood cancer
My team uses cutting edge single-cell techniques to understand normal human development and how normal development relates to disease. We focus on understanding and quantifying the nature and origins of cancer cells, particularly childhood cancers. To do this we combine the study of somatic genomic changes, bulk and single cell transcriptomics, and mathematical modelling of data.
Keywords
Cancer / somatic mutation / single-cell RNA sequencing / childhood cancer